Avata Biosciences Emerges to Develop Solid Dose Cannabinoid Medicines for Epilepsy and Other Neurological Diseases
Sapient Appoints Jonathan Usuka as Chief Business Officer
Sapient Extends Multi-Omics Services with High Throughput Discovery Proteomics